AU2010203096C1 — Boron-containing small molecules
Assigned to Anacor Pharmaceuticals LLC · Expires 2012-09-20 · 14y expired
What this patent protects
Boron-Containing Small Molecules Abstract This invention relates to compounds useful for treating fungal infections, more specifically topical treatment of onychomycosis and/or cutaneous fungal infections. This 5 invention is directed to compounds that are active against fungi an…
USPTO Abstract
Boron-Containing Small Molecules Abstract This invention relates to compounds useful for treating fungal infections, more specifically topical treatment of onychomycosis and/or cutaneous fungal infections. This 5 invention is directed to compounds that are active against fungi and have properties that allow the compound, when placed in contact with a patient, to reach the particular part of the skin, nail, hair, claw or hoof infected by the fungus. In particular the present compounds have physiochemical properties that facilitate penetration of the nail plate.
Drugs covered by this patent
- Eucrisa (Crisaborole) · Anacor Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.